baber/WOPTO huggingface dataset:
Patent NZ-334476-A (NZ)
Title: substituted indol-3-yl glyoxylamides
Inventor: LEBAUT GUILLAUME
IPC: A61P43/00
Filed: 1997-08-16
Abstract: The N-substituted indol-3-yl glyoxylamide has the formula I above or an acid addition salt thereof wherein: R is H or optionally phenyl substituted alkyl; R1 is optionally substituted phenyl, pyridinyl, 2- or 4-pyrimidinyl, or 2-, 3- or 4-pyridylmethyl, 2-, 3- or 4-quinolyl, 2-, 3-, or 4-quinolylmethyl or when R is H or benzyl R1 can be an acid radical or an amino acid which can be protected or R1 is allylaminocarbonyl-2-methylprop-1-yl or R and R1 together with the nitrogen atom to which they are attached form an optionally substituted piperazine or homopiperazine ring; R2 is H or optionally (halogen and/or or phenyl) substituted alkyl or optionally substituted  aroyl; R3 and R4 are independently H, OH, alkyl, cycloalkyl, alkanoyl, alkoxy, halogen or benzyloxy or are nitro, amino, mono- or di- substituted amino, alkoxycarbonylamino or alkyl and Z is O or S. A medicament thereof is useful for treating psoriasis, rheumatoid disorders and chronic polyarthritis.
Patent NZ-335187-A (NZ)
Title: A method to continuously treat wool
Inventor: GUISE BRUCE
IPC: D06L4/75
Filed: 1998-08-21
Abstract: A method for the continuous treatment of a web of wool slivers comprising the following steps separately and in order: (i) continuously treating said web with a non-ionic ethoxylated detergent, (ii) continuously treating said web with permonosulfuric acid or salts thereof, (iii) continuously treating said web with a sulfite containing solution, and (iv) continuously treating said web with an emulsion, dispersion or microemulsion of an aminofunctional polydimethylsiloxane.
Patent NZ-337634-A (NZ)
Title: method of inducing astroglial proliferation or promoting neuronal survival and/or proliferation by administering vascular endothelial growth factor (VEGF)
Inventor: HAYWARD NICHOLAS KIM
IPC: C12N5/0793
Filed: 1996-02-22
Abstract: A composition comprising a recombinant polypeptide comprising an amino acid sequence having at least 70% similarity to that of Sequence ID No. 6 and having at least one property in common with VEGF165 in the manufacture of medicaments for inducing astroglial proliferation or promoting neuronal survival and/or proliferation in a mammal. The recombinant polypeptide sequences are described are Seq ID 4, 8 an 10.
Patent NZ-502271-A (NZ)
Title: Block copolymer with soft and hard segments, the soft segments being cross-linked
Inventor: KAMIYAMA FUMIO
IPC: C09J151/00
Filed: 1998-07-10
Abstract: The specification describes a cross-linked block co-polymer of the A-B-A type having drug retention properties.  The block co-polymer, preferably an acrylic block co-polymer,  has hard and soft segments and is characterized in that there is cross-linking between the segments.  The block co-polymer is an adhesive when in conjunction with one or more enhancing agents. The soft portion of the block co-polymer comprises monomeric units selected from alkyl acrylates and alkyl methacrylates.  The hard segment polymer is formed from styrene and/or polymethyl methacylate.
Patent NZ-503797-A (NZ)
Title: Data transmission protocol protection
Inventor: DE LA BRETONIERE PALPH ROGIER
IPC: H04N1/32
Filed: 1998-10-09
Abstract: A method for protecting data communication traffic between a first communication station (11) and a second communication station (12), in which the data is dispatched according to a data protocol from the second to the first communication station, includes the steps of the comparison of the data protocol with at least one standardized protocol and the forwarding only of data of which the data protocol complies with the at least one standardized protocol to the first communication station (11). For this purpose, the device (10) includes a memory (14) in which data characteristics of at least one standardized protocol have been stored and a comparison/forwarding module (15) which compares the stored data characteristics with the data protocol of the data from the respective station and forwards only data of which the data protocol complies with the at least one standardized protocol to the other station.  Data that does not comply with the protocol is not forwarded.
Patent NZ-504649-A (NZ)
Title: Alumina-supported ruthenium catalyst
Inventor: MAENO HIRONOBU
IPC: B01J21/10
Filed: 1997-11-27
Abstract: A ruthenium-on alumina catalyst comprising at least a ruthenium component carried by a porous a-alumina material. The catalyst has a specific surface area of 7-50m2/g and ratio of S1/S2 of the specific area of the ruthenium-on-alumina catalyst (S1) to the surface area of the porous a-alumina material (S2) of 3-50.
Patent NZ-506653-A (NZ)
Title: Detectable earplug and method of manufacture thereof
Inventor: FALCO ROBERT N
IPC: A61F11/08
Filed: 1999-12-06
Abstract: An earplug (10) including a foam body (14) and a detectable insert (12) completely encased by the foam body (14).  The earplug (10) is manufactured by forming a channel in the foam body (14) and placing the detectable insert (12) in the channel.  The channel is formed by deforming the foam body (14) using a punch.  The foam body (14) is made from a slow recovery foam which returns to its original shape thereby encapsulating the detectable insert (12) within the foam body (14).  In an alternative embodiment, the detectable insert (12) is projected into the foam body (14) and the foam body (14) recovers to encapsulate the insert (12).
Patent NZ-509795-A (NZ)
Title: Water soluble prodrugs of hindered alcohols or phenols
Inventor: STELLA VALENTINO J
IPC: C07F9/6515
Filed: 1999-08-06
Abstract: A compound of formula (I) or (IV) or pharmaceutically acceptable salts thereof wherein: R-O- is a is a residue of a phenol containing pharmaceutical compound excluding taxol and taxol derivatives; R1 and R2 independently are hydrogen, an alkali metal ion, a protonated amine or a protonated amino acid; Y is a phosphono protecting group; n is 1 or 2 and m is at least 1.
Patent NZ-511226-A (NZ)
Title: Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder
Inventor: CARLSSON MARIA
IPC: A61K9/68
Filed: 1999-10-29
Abstract: Use of a nicotine receptor agonist or a pharmaceutically acceptable salt thereof for the production of a pharmaceutical preparation for the treatment of obsessive compulsive disorder is disclosed, as well as a method for treatment of a patient suffering from obsessive compulsive disorder, comprising the administration of a nicotine receptor agonist or a pharmaceutically acceptable salt thereof, in an amount effective in alleviating, reducing or abolishing one or several of the symptoms of obsessive compulsive disorder.
Patent NZ-512388-A (NZ)
Title: Vehicle roof attachment device and manufacturing method therefor
Inventor: BENNETT MICHAEL HEBDEN
IPC: B60R9/04
Filed: 2001-07-19
Abstract: A  vehicle  roof  attachment device  (1)  comprises  a support  member (2) shaped or deformable so as  to  fit  the surface  of a vehicle roof, and a strap (3) passing  through the  support  member (2) and protruding  from  the  opposite ends (4, 5) thereof.  The strap (3) is integrally bonded  to the  support member (2) about the strap (3).  The strap  (3) is  fitted with a double ring (6) at one end (7) into  which an  other end (8) can be inserted and wrapped back to enable optional  tension adjustment when the attachment device  (1) is  fitted to the roof a vehicle, with the strap (3)  passed through  the  doors or windows of the vehicle.   Moreover  a load securing device is provided in the form of D-rings  (9, 10)  attached to the strap (3) at the opposite ends  (4,  5) of the support member (2).
Patent NZ-516736-A (NZ)
Title: Preserved pharmaceutical formulations
Inventor: GAYED ATEF
IPC: A61K9/10
Filed: 2000-07-21
Abstract: A pharmaceutical composition comprising a pharmacologically active ingredient and an amount of benzethonium chloride and an amount of phenozyethanol wherein the amount of benzethonium chloride and phenozyethanol are effective to inhibit microbial growth, and wherein the composition is not formulated for topical administration.
Patent NZ-517759-A (NZ)
Title: Kinase inhibitors as therapeutic agents
Inventor: HIRST GAVIN C
IPC: A61P19/02
Filed: 2000-09-15
Abstract: A compound selected from various core structures which may include but is not limited to formulae 1 to 12. The compound is used to inhibit protein kinase activity, namely serine/threonine or tyrosine kinases. A compound as described above may be used to treat conditions such as cancer, inflammatory conditions, ocular conditions, cardiovascular disease (such as atherosclerosis and carotid obstructive disease) and diabetes.
Patent NZ-521241-A (NZ)
Title: Azole compounds as therapeutic agents for fungal infections
Inventor: VERMA ASHWANI KUMAR
IPC: C07D249/14
Filed: 2001-03-01
Abstract: Described are derivatives of specially substituted azole compounds which have improved antifungal activity as compared to known compounds such as fluconazole and itraconazole and the processes for the preparation thereof. Also described are pharmaceutical compositions containing the compounds of the present invention and their use in treating and/or preventing fungal infections in mammals, preferably humans.
Patent NZ-525383-A (NZ)
Title: Method for producing acetic acid
Inventor: ZEYSS SABINE
IPC: C07C53/08
Filed: 2001-10-17
Abstract: A process for the production of acetic acid is disclosed, which involves oxidation of ethane with molecular oxygen in a fluidised bed of catalyst particles, wherein the particle diameter of at least 70% of the catalyst particles have diameter 80 mm or less, the density of the catalyst particle used in the fluidised bed reactor is in the range of 500 kg/m3 to 6000 kg/m3, the fluidised bed index is greater or equal to 1 and the gas volume flow is selected so that the gas bubble diameter of the reaction gas mixture fed in the fluidised bed reactor is less than 12 cm.
Patent NZ-527539-A (NZ)
Title: Analysis of general diagnostic factors in cells and body fluids
Inventor: SHAI SHAFRIRA
IPC: G01N33/487
Filed: 1999-03-16
Abstract: A method of inducing an acrosome reaction in sperm cells by incubating said cells in a solution containing a calcium ionophore and a plantinic salt. Also claimed is a method of monitoring an acrosome reaction in sperm cells comprising incubating said cells as described above and monitoring the reaction using an anti-CD46 antibody.
Patent NZ-531025-A (NZ)
Title: Vaccine comprising a mutant rabies virus N protein which has an amino acid other than serine at position 389 and possibly one or more other mutations within the N protein
Inventor: FU ZHEN FANG
IPC: C12N7/01
Filed: 2002-07-22
Abstract: A mutant virus is provided that contains a mutation at a phosphorylation site in one or more of the proteins of the virus, which mutation causes the virus to be attenuated, and therefore, a vaccine composition can be produced with that mutant virus. Also described are vaccine compositions, which contain the mutant virus, as well as methods of inducing an immune response, and of protecting mammals from infection by rabies virus. Also included are methods of producing the mutant virus and mutant viral proteins, including producing the mutant virus in an isolated host cell that produces or even overproduces a wild-type counterpart of the mutant viral protein, which complements the other viral proteins such that production of the mutant viral particle is optimised. Also included are those host cells in which viral production is optimised, as well as vaccine compositions including the viral proteins, either alone or in combination with the intact virus, and methods of inducing an immune response or protecting a mammal from infection, using the same. Also included are vectors suitable for delivering a gene to a cell of a human or animal, as well methods of delivery thereof.
Patent NZ-533563-A (NZ)
Title: Box filling machine using expandable funnel
Inventor: NEYLON BRENDAN JOHN
Filed: 2004-06-15
Abstract: Methods and apparatus for machine assisted loading of a box with discrete articles are disclosed. The box is located below a filling funnel that is then inserted into the box in a compact form. The funnel is reconfigurable so that it can be deployed to a size closer to the size of the box following insertion. The articles are dropped through the funnel following its reconfiguration to a larger size.
Patent NZ-534908-A (NZ)
Title: Extrudate cutting device
Inventor: ALEXANDER DAVID
IPC: B29C48/30
Filed: 2004-08-26
Abstract: A method of producing a textured proteinaceous meat analogue with an optimised fibrous appearance from extrudate which passes through a conduit of known cross-sectional shape. The method comprises the steps of: determining a cutting profile for the extrudate, making a slice through the extrudate that is substantially co-linear with the longest axis of the cross-sectional shape via one or more blades adapted to slice in a manner according to the above profile in a direction substantially opposed to the direction of flow of the extrudate through the conduit. The cross-sectional shape may be rectangular where the at least one blade slices through the extrudate in an orientation that is parallel with the longest dimension of the rectangular shape. Alternatively the cross-sectional shape may be circular where the cutting profile includes at least one circular slice that is concentric with the circular profile. The method may also involve the step of cooling the extrudate prior to cutting.
Patent NZ-535793-A (NZ)
Title: Epoxysilicone coated asymmetric membranes
Inventor: CHIOU JEFFREY J
IPC: B01D53/22
Filed: 2002-04-03
Abstract: A method for preparing an epoxysilicone coated asymmetric membrane is disclosed, wherein the method comprises: (a) casting a porous asymmetric membrane layer; (b) drying the porous asymmetric membrane layer to form a dry porous asymmetric membrane; (c) uniformly coating the dry porous asymmetric membrane with a coating comprising a dilute epoxysilicone solution to form a coated membrane; and (d) irradiating and drying the coated membrane to produce the epoxysilicone coated membrane. Preferably, the method comprises coating a porous asymmetric membrane layer with a UV-curable controlled release epoxysilicone coating. A mixture of the epoxysilicone resin and an onium photocatalyst are applied to the porous asymmetric membrane layer in a dilute non-polar solution and cured by UV or electron beam radiation to produce a dry epoxysilicone coated membrane. The porous asymmetric membrane layer is comprised of an asymmetric cellulosic membrane or an asymmetric polymer membrane with a low selectivity. The epoxysilicone coating was found to provide the asymmetric membrane layer with improved selectivity which extends to separation temperatures below 70 degree C and provides stable flux rates. Membranes produced in this manner are useful for the separation of gases such as carbon dioxide from natural gas.
Patent NZ-536231-A (NZ)
Title: Determining the presence of antibiotic-inactivating factors such as antibiotic-inactivating enzymes using an agent that enhanced permeability of the assay culture
Inventor: BLACK JENNIFER A
IPC: C12Q1/18
Filed: 2003-03-13
Abstract: Disclosed is a method of determining the antibiotic susceptibility of a microorganism comprising the following steps: First, a culture of the microorganism whose susceptibility is to be determined is admixed with an antibiotic to which susceptibility is to be assayed, and a permeabilizing agent for the microorganism present in a non-growth-inhibiting microorganism-permeabilizing effective amount to form an assay culture. Next, the assay culture is incubated under appropriate culture conditions and for a time sufficient to determine the susceptibility of the microorganism to the antibiotic. Significant growth in the assay culture is indicative of resistance of the microorganism to the antibiotic.
Patent NZ-538909-A (NZ)
Title: Treeless jumping saddle and method of making the same
Inventor: DECOSEMO PETER A
IPC: A63B/
Filed: 2003-08-14
Abstract: A treeless saddle comprises a layered arrangement of flexible leather and foam, without including a rigid saddletree or frame. In particular, the saddle comprises two lower body half sections sewn together to define a saddle body. An underside of said saddle body includes two back contacting pads that define a recessed gullet region there between. A removable gullet pad may be provided for releasable securement with the gullet region. The saddle further comprises additional layers of soft leather and foam shaped to define an upwardly extending pommel, an upwardly extending cantle, and a lowered seat area positioned there between. The arched and contoured shape of the saddle, therefore, is defined by soft foam and leather and not by a rigid steel or wooden internal frame.
Patent NZ-539454-A (NZ)
Title: Multimode phone including two wireless modems and a modem processor
Inventor: YUKIE SATORU
IPC: H04B1/38
Filed: 2003-09-26
Abstract: Methods and apparatus are disclosed for controlling a wireless handset including two wireless modems. In one implementation, a phone includes: a first wireless modem including a controller; a first antenna connected to said first wireless modem; a second wireless modem connected to said first wireless modem; a second antenna connected to said second wireless modem; and a user interface connected to said first wireless modem; wherein said first wireless modem controls the operation of said second wireless modem and said user interface, said first wireless modem provides a first air interface, said second wireless modem provides a second air interface, and said first air interface is different from said second air interface.
Patent NZ-540794-A (NZ)
Title: Vascular-preferred promoters
Inventor: PHILLIPS JONATHAN
IPC: A01H5/00
Filed: 2003-11-21
Abstract: Disclosed is an isolated nucleic acid molecule comprising a polynucleotide of SEQ ID NO: 47 or a functional variant thereof that is capable of conferring preferred polynucleotide transcription in a vascular tissue cell in a plant. Also disclosed is a plant cell transformed with said isolated nucleic acid molecule, and a method for obtaining wood utilizing said plant cell.
Patent NZ-544157-A (NZ)
Title: Pharmaceutical composition comprising cyclic somatostatin analogues
Inventor: LAMBERT OLIVER
IPC: C07K7/06
Filed: 2004-06-23
Abstract: Disclosed are compositions comprising somatostatin compounds of formula II, wherein the substituents are as defined in the specification, and tartaric acid.
Patent NZ-546916-A (NZ)
Title: Method for producing N-substituted 3-beta-aminonortropanes
Inventor: SOBOTTA RAINER
IPC: C07D451/04
Filed: 2004-10-05
Abstract: Disclosed is a method for producing, on the basis of the corresponding 3-oxonortropane or the corresponding 3alpha-aminonortropane, N-substituted 3beta-aminonortropanes of formula (I), wherein R1 is as defined in the specification. The starting compounds are converted to the corresponding imines by means of an arylmethylamine or an arylaldehyde, said imines are tautomerized or isomerized and then hydrolyzed. Also disclosed are novel compounds of formula (V), wherein R1 and Ar are as defined in the specification.
Patent NZ-552248-A (NZ)
Title: A method and apparatus for controlling heat transfer for a fluid immersed vessel
Inventor: WALKER DARREL J
IPC: F25D31/00
Filed: 2005-06-20
Abstract: A temperature control system for cooling food at an optimal temperature is disclosed. The system includes a pan for holding food (28), a cooling device (40), first and second insulation members (42, 44), and a channel filled with glycol coolant medium (36). The pan (28) has an opening, a lateral side wall, and a bottom for holding the food. The cooling device (40) cools the opening (32) more than it cools the bottom (34). The side wall (30) has the first insulation member (42) around it and the second insulation member (44) surrounds the first insulation member and the sidewall (30). The channel (36) is defined between the lateral wall (30) and the second insulation member (44) and is wider near the sidewall (36) than near the bottom (34).
Patent NZ-554740-A (NZ)
Title: Neutralizing human anti-IGFR antibody
Inventor: WANG YAN
IPC: A61P35/00
Filed: 2003-05-22
Abstract: Disclosed is a pharmaceutical composition comprising an isolated antibody or antigen-binding fragment thereof that binds to IGFR1 comprising a CDR-L1, CDR-L2 and CDR-L3 found in a light chain variable region which comprises the amino acid sequence set forth in SEQ ID NO: 78 ; or a CDR-H1, CDR-H2 and CDR-H3 found in a heavy chain variable region which comprises the amino acid sequence set forth in SEQ ID NO: 45; or both; and a pharmaceutically acceptable carrier which comprises water, buffer and sugar. Also disclosed are uses of the said composition.
Patent NZ-556583-A (NZ)
Title: Low friction, direct drive conveyor belt
Inventor: DEGROOT MICHAEL
IPC: B65G23/06
Filed: 2006-01-19
Abstract: A direct drive conveyor 129 comprising an endless belt, stretchable through its length, at least one drive pulley wherein one of the belt and the pulley has teeth 106 and the other of the belt and the pulley has sheaves 104 adapted to receive the teeth as the belt wraps around the pulley to an exit point wherein the drive pulley and the belt have different pitches, and a position limiter 200 disposed against the belt near the exit point so that the driven tooth will stay engaged with the recess in which the driven tooth is received for rotation of the pulley equivalent to more than the length of one pulley pitch.
Patent NZ-564378-A (NZ)
Title: Methods and systems for delivering foamed beverages from liquid concentrates through a dispenser machine
Inventor: SAGGIN RAFFAELLA
IPC: B67D7/74
Filed: 2006-06-16
Abstract: A method and system to deliver foamed beverages from liquid concentrate(s) through a dispenser machine is disclosed. In an embodiment, the method and system for improving foam quality by generating foam with the desired texture, stability and bubble size distribution comprises use of a low viscous liquid(s) to generate a primary foam, which is then stabilized by mixing it with liquid(s) of higher viscosity. To create high quality foam, different dosing protocols including two approaches such as delivery of foaming liquid concentrates at different concentration, or getting different concentration by varying water dosing times and/or flow rates were used. Positive results were found for the dispensing systems using milk and other liquid concentrates at specific dispensing conditions (flow rates and times).
Patent NZ-568241-A (NZ)
Title: Antibodies against amyloid beta 4 with glycosylation in the variable region
Inventor: LOETSCHER HANSRUEDI
IPC: A61K39/395
Filed: 2006-12-11
Abstract: Disclosed is a composition comprising an antibody molecule capable of specifically recognizing the beta-A4 peptide/Abeta4, said antibody molecule being a mono-glycosylated antibody molecule or a double-glycosylated antibody molecule or wherein said composition comprises a mixture of said mono-glycosylated antibody molecule and said double-glycosylated antibody molecule, - wherein said mono-glycosylated antibody molecule comprises one glycosylated asparagine (Asn) at position 52 of SEQ ID NO: 2 or SEQ ID NO: 6 in the variable region of the heavy chain (VH) and wherein said double-glycosylated antibody molecule comprises a glycosylated asparagine (Asn) at position 52 of SEQ ID NO: 2 or SEQ ID NO: 6 in the variable region of the heavy chain (VH) of both antibody binding sites, - wherein said antibody molecule comprises a CDR1 in the variable heavy chain as shown in SEQ ID NO: 10, a CDR2 in the variable heavy chain as shown in SEQ ID NO: 12, a CDR3 in the variable heavy chain as shown in SEQ ID NO: 14, a CDR1 in the variable light chain as shown in SEQ ID NO: 16, a CDR2 in the variable light chain as shown in SEQ ID NO: 18 and a CDR3 in the variable light chain as shown in SEQ ID NO: 20, and whereby said composition comprises less than 5% of an antibody molecule lacking an antigen binding site which comprises a glycosylated asparagine (Asn) in the variable region of the heavy chain (VH).